Pharmafile Logo
Pharmafocus logo
Advanced Search
hans_wijers

GSK appoints Hans Wijers to its Board as a non-executive director

January 28, 2013
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing GSK, hans Wijers

GSK has confirmed the appointment of Hans Wijers to its Board as a non-executive director with effect from April.  The …

Appointment
J&J image

J&J seeks end to Doxil shortage as Ben Venue signs consent decree

January 28, 2013
Manufacturing and Production Ben Venue, Boehringer, Caelyx, Doxil, J&J, JJ, Janssen

Johnson & Johnson says it has taken steps to establish new supplies of its cancer drug Doxil/Caelyx, which remains in …

News
cell vaccine image

Vaccine manufacturing emerges as outsourcing market

January 28, 2013
Manufacturing and Production R&D, Vaccine, outsourcing

Healthy growth in the market for vaccines – coupled with high production costs – look set to create a vaccine …

News

Life Tech gets bigger in bioproduction with BAC buy

January 28, 2013
Manufacturing and Production BAC, Life Technologies

Life Technologies has expanded its position in bioprocessing technologies with the acquisition of Dutch protein purification specialist BAC. Carlsbad, US-based …

News

Scotland’s medicines bill can shrink further, says report

January 25, 2013
Sales and Marketing PPRS, Scotland, VBP, prescribing

An official review of primary care prescribing in Scotland has welcomed savings made, but says further efficiencies are possible.Audit Scotland …

News

Abbott finishes strongly before spin-off

January 25, 2013
Sales and Marketing AbbVie, Abbott, Q4 2012

Abbott has presented its full-year results for 2012 – the last in which many of its products will appear, following …

News

NICE recommends two cystic fibrosis treatments

January 25, 2013
Sales and Marketing Colobreath, Forest Labs, Novartis, Tobi Podhaler, cystic fibrosis

NICE has given final recommendation to two new inhalers for cystic fibrosis (CF) patients.Forest Lab’s Colobreath (colistimethate sodium) and Novartis’ …

News

Allergan in $958m neurology deal

January 25, 2013
Sales and Marketing Allergan, CNS, MAP Pharmaceuticals, migraine

Allergan is to pay $958m for MAP Pharmaceuticals in a deal which sees both companies hoping to reap the benefits …

News

Flying start to 2013 for Watermeadow Medical

January 24, 2013
Medical Communications

Watermeadow Medical has started the new year with an office relocation from Knutsford to fully refurbished, larger office space in …

Appointment

Novartis’ 2012 results flat

January 24, 2013
Sales and Marketing Bexsero, Jakavi, Novartis, generics, results

Generic competition has put a dent in Novartis’ financial results for 2012, with net sales down 3% year on year …

News
Novo Nordisk image

EU approval for Novo Nordisk diabetes drugs

January 24, 2013
Sales and Marketing Novo Nordisk, Ryzodeg, Tresiba

Novo Nordisk is celebrating after European regulators approved two of its drugs for the treatment of adults with diabetes. The …

News

Jörg Reinhardt to leave Bayer for Novartis

January 24, 2013
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Bayer, Novartis, Reinhardt

The chairman of the Board and member of the Bayer executive council Dr Jörg Reinhard is stepping down from his …

Appointment
Watson image

Watson buys women’s health specialists

January 23, 2013
Research and Development, Sales and Marketing Actavis, Uteron, Watson, women

Watson has completed the acquisition of Uteron Pharma, a Belgium R&D-based firm specialising in women’s health products. The world’s third-largest …

News
novartis image

EU approval for meningitis vaccine

January 23, 2013
Sales and Marketing Bexsero, CHMP, Novartis, meningitis

European regulators have approved Novartis’ Bexsero, making it the first broad coverage vaccine to target the leading cause of meningitis. …

News

New drug discovery alliance launches

January 23, 2013
Research and Development, Sales and Marketing CDRD, LDC, translational research

Six of the world’s top health science centres have banded together in an attempt to speed up the rate at …

News
john_reed

Roche adds head to corporate executive committee

January 23, 2013
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing John Reed, Roche

Roche has announced that John Reed has been appointed as head of Roche Pharma Research and Early Development (pRED) and …

Appointment
Ark Therapeutics image

Ark Therapeutics mulling fundraising options

January 22, 2013
Manufacturing and Production Ark Therapeutics

Contract development and manufacturing services company Ark Therapeutics has been forced to abandon proposals to raise money via an equity …

News
FDA image

Germany’s Hameln warned by FDA over GMP failings

January 22, 2013
Manufacturing and Production FDA, GMP, Hameln

German contract manufacturer Hameln Pharmaceuticals was sent a warning letter by the FDA last month detailing a number of Good …

News
Allergan image

Botox US bladder indication

January 22, 2013
Sales and Marketing Allergan, Botox, FDA, bladder

Allergan’s Botox has been given approval by the FDA for the treatment of overactive bladder (OAB) in adults.Botox (onabotulinumtoxinA) has …

News

Lundbeck sells $100m portfolio

January 22, 2013
Sales and Marketing Lundbeck, OTC, Panhematin, Recordati

Italian pharma group Recordati has paid $80 million to Lundbeck for a portfolio of products primarily aimed at the US …

News
The Gateway to Local Adoption Series

Latest content

Stage4You encourages stage 4 bowel cancer patients to prioritise mental health ahead of Bowel Cancer Awareness Month

March 26, 2026

Scotland starts newborn screening for SMA

March 26, 2026

Secarna appoints Jens Holstein and Richard Mark Engelhard to new Advisory Board

March 25, 2026

Roche adds 2,176 NVIDIA Blackwell GPUs to its hybrid-cloud AI factory

March 25, 2026

ReproNovo appoints Mark Altmeyer as Chairman of the Board

March 24, 2026